Levosimendan Administration and Outcome in Cardiac Surgery

Charité University Medicine Berlin

Status: Completed

Conditions: Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery

Treatments: Drug: Levosimendan

Study type: Observational

Funder types: Other

Identifiers

NCT02275013

ea1-044-13b

Details and patient eligibility

About

To assess the effects on outcome of levosimendan with respect to timing of its administration on the postoperative course of high-risk cardiac surgery patients in a retrospective observational study.

Enrollment: 159 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients undergoing cardiac surgery between 2006 and 2013
• levosimendan administration within 24 hours of postoperative ICU admission

Exclusion criteria

• patients younger than 18

Trial design

159 participants in 2 patient groups

Early

Description:

Levosimendan administration within first hour of post-operative ICU admission

Treatment:

Drug: Levosimendan

Late

Description:

Levosimendan administration within 24 hours of post-operative ICU admission but after first hour

Treatment:

Drug: Levosimendan